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Experimental part
Solvents and all reagents were obtained from standard commercial vendors and used without additional purification.
Sonication was carried out with help of standard ultrasonic bath producing irradiation at 44.2 kHz in a round-bottomed flask equipped with a condenser.
Melting points were measured on a standard melting point apparatus in open capillary tubes and were uncorrected. 
General procedure for the preparation of N-aryl-2-hydroxy-2-methyl-4-(3-
methylisoxazol-5-ylamino)-3,4-dihydro-2H-chromene-3-carboxamides 4a-h.
The mixture containing 1 mmol of 3-methylisoxazol-5-amine (1), 1 mmol of salicylaldehyde (2), 1 mmol of the appropriate N-aryl-3-oxobutanamide 3a-h and 3 mL of ethanol was continuously ultrasonicated at room temperature for 4 h. Then the reaction mixture was set aside for a day.
The solid precipitated was collected by filtration and vacuum dried. The target compounds were obtained in high purity (ca. 95% according to TLC and NMR and elemental analysis) and no additional recrystallization was needed. Some of the compounds 4 were isolated as a mixture of diastereomers. In these cases only the signals of major diastereomer are given for NMR spectra. Also, these compounds become unstable even with a slight heating and are prone to decay in NMR tube. 
2-Hydroxy-N-(2-methoxyphenyl)-2-methyl-4-(3-methylisoxazol-5-ylamino)-3,4-dihydro-
2H-chromene-3-carboxamide (4a
N-(2-Chlorophenyl)-2-hydroxy-2-methyl-4-(3-methylisoxazol-5-ylamino)-3,4-dihydro-
2H-chromene-3-carboxamide (4e
N-(2,4-Dimethylphenyl)-2-hydroxy-2-methyl-4-(3-methylisoxazol-5-ylamino)-3,4-
dihydro-2H-chromene-3-carboxamide (4g
2-Hydroxy-N-(2-hydroxyphenyl)-2-methyl-4-(3-methylisoxazol-5-ylamino)-3,4-dihydro-
2H-chromene-3-carboxamide (4h
N-(2-Ethoxyphenyl)-4-(2-hydroxyphenyl)-3,6-dimethyl-4,7-dihydroisoxazolo[5,4-b]pyridine-5-carboxamide (5c
